Aktuellt
SENASTE
Redeye comments on Genovis Q1 2023, which delivered a beat on practically all metrics on the back of the milestone from Selecta/Astellas. We expect a positive reaction in the share and will likely slightly upwards adjust our forecasts and fair value range.
LÄS MER
